Pradžia › Inkstinis nepakankamumas › Florida
Inkstinis nepakankamumas klinikiniai tyrimai Florida
14 tyrimai dėl Inkstinis nepakankamumas ieško dalyvių vietose Florida.
Miestai Florida
Oficialus tyrimo tekstas (anglų kalba)
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
- Kailera Clinical Site, Orlando
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07793929A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
- Cleveland Clinic Weston Hospital, Weston
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-25 · NCT05805709A Clinical Trial of Nemtabrutinib in Participants With Severe Kidney Disease (MK-1026-027)
- Floridian Clinical Research, LLC ( Site 0001), Miami Lakes
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-23 · NCT07734610Product Surveillance Registry
- Bradenton
- Clearwater
- Davie
- ir dar 7
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-09-18 · NCT01524276A Study Investigating the Safety of RO7795081 and How the Body Processes RO7795081 in People With Normal or Decreased Kidney Functions
- Panax Clinical Research, LLC, Miami Lakes
- GCP Research - Florida, St. Petersburg
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07741604Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- D&H Doral Research Center, Doral
- AGA Clinical Trials, Hialeah
- Convenient Medical Center, Hialeah
- ir dar 13
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07271186Study of the Effect of Haemodialysis on the Pharmacokinetics, Safety, and Tolerability of Balcinrenone/Dapagliflozin
- Research Site, Orlando
Renkami dalyviai1 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-04 · NCT07754331SPYRAL GEMINI Pilot Study
- Orlando Health Heart & Vascular Institute, Orlando
- BayCare Health System Mease Countryside Hospital, Safety Harbor
Renkami dalyviai
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-06-24 · NCT06907147A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
- Floridian Clinical Research, Miami Lakes
- Orlando Clinical Research Center, Orlando
Renkami dalyviai1 fazė
Amžius nuo 18 iki 85 · Visoms lytims · Atnaujinta 2026-06-16 · NCT07559396A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
- Orlando Clinical Research Center, Orlando
- Genesis Clinical Research, LLC, Tampa
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-05-12 · NCT07315360Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
- Cleveland Clinic Florida, Weston
Renkami dalyviai
Amžius nuo 22 iki 85 · Visoms lytims · Atnaujinta 2026-03-19 · NCT07017933SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- Tallahassee Research Institute, Tallahassee
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-02-17 · NCT06001827Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
- Mayo Clinic, Jacksonville
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-01-28 · NCT06752577A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- Sarasota Memorial Hospital, Sarasota
- University of South Florida, Tampa
Renkami dalyviai
Amžius nuo 18 iki 90 · Visoms lytims · Atnaujinta 2025-12-22 · NCT04671771Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.